|0.17|| -0.01 / -5.56%|
Echo Therapeutics is a medical device company. It develops non-invasive, wireless continuous glucose monitoring (CGM) system with use in the wearable-health consumer market and the diabetes outpatient market. The company is developing its prelude skinprep system as a platform technology to allow for skin permeation that will enable two important applications: Analyte extraction, with the Symphony CGM System for needle-free, continuous glucose monitoring in critical patients as the first application and Needle-free drug delivery, with the delivery of lidocaine as the first application. Echo Therapeutics was founded on September 14, 2007 and is headquartered in Iselin, NJ.
|Alan Wayne Schoenbart||Chief Executive Officer, CFO & Secretary|
|Christine H. Olimpio||Director-Investor Relations & Communications|